Editorial for "Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments"

被引：0
|
作者：
Horng, Debra E. [1 ]
机构：
[1] Deb Horng Consulting LLC, Philadelphia, PA 15238 USA
来源：
JOURNAL OF MAGNETIC RESONANCE IMAGING | 2024年 / 59卷 / 06期
关键词：
D O I：
10.1002/jmri.29018
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：2202 / 2203
页数：2
相关论文
共 50 条
  • [31] Depressive symptoms and monoaminergic network changes in multiple sclerosis: a longitudinal study
    Mistri, Damiano
    Valsasina, Paola
    Storelli, Loredana
    Rocca, Maria Assunta
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 159 - 159
  • [32] Depressive symptoms and monoaminergic network changes in multiple sclerosis: a longitudinal study
    Mistri, D.
    Valsasina, P.
    Storelli, L.
    Rocca, M.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 637 - 637
  • [33] A 5 year longitudinal MRI study of ventricular volume in primary progressive multiple sclerosis
    Ingle, GT
    Stevenson, VL
    Leary, SM
    Miller, DH
    Thompson, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02): : 217 - 217
  • [34] Serpina3n: potential biomarker in patients with progressive multiple sclerosis
    Fissolo, N.
    Issazadeh-Navikas, S.
    Dujmovic, I.
    Voortman, M.
    Khalil, M.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 219 - 219
  • [35] Treatments of paediatric multiple sclerosis: Efficacy and tolerance in a longitudinal follow-up study
    Saponaro, Anne-Charlotte
    Tully, Thomas
    Maillart, Elisabeth
    Maurey, Helene
    Deiva, Kumaran
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 45 : 22 - 28
  • [36] Longitudinal change in TSPO PET imaging in progressive multiple sclerosis
    Kang, Yeona
    Pandya, Sneha
    Zinger, Nicole
    Michaelson, Nara
    Gauthier, Susan A.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (08): : 1755 - 1759
  • [37] Neuroprotective Potential of Fumaric Acid Esters in a Model of Multiple Sclerosis
    Racke, Michael K.
    Peng, Hai-yan
    Akyol, Elif
    Lovett-Racke, Amy E.
    Pitt, David
    NEUROLOGY, 2011, 76 (09) : A385 - A386
  • [38] Longitudinal changes in metabolic neuroimaging markers linked to the clinical decline in patients with secondary progressive multiple sclerosis
    Choi, I. -Y.
    Lee, P.
    Hughes, A. J.
    Denney, D. R.
    Lynch, S. G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 858 - 859
  • [39] Mitoxantrone as a potential therapy for primary progressive multiple sclerosis
    Stüve, O
    Kita, M
    Pelletier, D
    Fox, RJ
    Stone, J
    Goodkin, DE
    Zamvil, SS
    MULTIPLE SCLEROSIS JOURNAL, 2004, 10 : S58 - S61
  • [40] Progressive multiple sclerosis 3 Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
    Ontaneda, Daniel
    Fox, Robert J.
    Chataway, Jeremy
    LANCET NEUROLOGY, 2015, 14 (02): : 208 - 223
12345